CLINICAL & EXPERIMENTAL METASTASIS is a highly regarded academic journal dedicated to the study of cancer metastasis, published by Springer. With an ISSN of 0262-0898 and an E-ISSN of 1573-7276, this journal serves as a pivotal resource for researchers and professionals dedicated to understanding the complexities of metastatic disease. Based in the Netherlands, it boasts an impressive impact factor, solidifying its position in two major quartiles: Q2 in Cancer Research and Q1 in both Medicine (Miscellaneous) and Oncology for 2023. The journal not only ranks among the top tier in Medicine Oncology—84th out of 404—but also excels in Biochemistry, Genetics and Molecular Biology in Cancer Research, ranking 75th out of 230. With coverage spanning from 1983 to 2024, CLINICAL & EXPERIMENTAL METASTASIS presents cutting-edge research, reviews, and clinical studies that drive the field forward. This journal is essential for anyone looking to deepen their understanding of cancer metastasis and its underlying mechanisms.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

PANCREAS, published by Lippincott Williams & Wilkins, is a preeminent journal dedicated to advancing the field of endocrinology, diabetes, hepatology, and internal medicine. With an ISSN of 0885-3177 and E-ISSN of 1536-4828, this journal aims to disseminate high-quality research findings and clinical insights that are pivotal for professionals in these areas. The journal has established itself with an impressive Q2 ranking across multiple categories in the 2023 rankings, including endocrinology, diabetes and metabolism, hepatology, and internal medicine. Although it offers no open access options, the content is meticulously curated to enrich the knowledge base of researchers and practitioners. The Scopus rankings further underscore its influence, ranking #64 in Internal Medicine and #36 in Hepatology, reflecting its commitment to scholarly excellence. Based in the United States at Two Commerce Square, 2001 Market St, Philadelphia, PA 19103, PANCREAS serves as a central hub for innovative research from 1986 to 2024, making it an essential resource for those engaged in these rapidly evolving fields.

Zentralblatt für Chirurgie is a pivotal journal in the realm of surgical medicine, serving as an essential resource for researchers, professionals, and students in the field. Published by Georg Thieme Verlag KG, this journal has been disseminating vital surgical research since its inception in 1947, fostering a robust dialogue among healthcare practitioners worldwide. While currently positioned in the Q4 quartile for both Medicine and Surgery in 2023, Zentralblatt für Chirurgie remains a valuable platform for disseminating innovative findings, case studies, and critical reviews that shape contemporary surgical practices. With a rich archive and a commitment to enhancing surgical knowledge, this journal is ideally suited for those seeking to stay abreast of current trends and developments within the medical landscape. Although it does not provide open access, its contents continue to be a crucial asset for institutions and professionals dedicated to surgical excellence.

The Journal of Visceral Surgery, an esteemed publication from Elsevier Masson, offers a crucial platform for disseminating innovative research in the field of visceral surgery. Operating since 2010 and continually evolving through to 2024, this journal is dedicated to presenting high-quality studies and clinical findings that advance the practice and understanding of surgical techniques and patient care in visceral surgery. With an ISSN of 1878-7886 and a notable impact within the academic community, it achieved a Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in Surgery as of 2023, reflecting its growing influence in the surgical domain. Although it currently does not operate under an Open Access model, the journal remains committed to informing a diverse audience of scholars, practitioners, and students about pioneering methods, case studies, and reviews within the discipline. Positioned in France, the journal serves as an indispensable resource for enhancing surgical practice and fostering collaboration among professionals globally, making it a vital read for anyone invested in the advancement of visceral surgery.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.

Annals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.